Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study

• Autores: Lopes, Luciane C.; Salas, Daiana Maribel; Osorio de Castro, Claudia Garcia Serpa; Freitas Leal, Lisiane; Doubova, Svetlana V.; Cañás, Martín; Dreser, Anahi; Acosta, Angela; Oliveira Baldoni, Andre; de Cássia Bergamaschi, Cristiane; Marques Mota, Daniel; Gómez Galicia, Diana L.; Sepúlveda Viveros, Dino; Narvaez Delgado, Edgard; da Costa Lima, Elisangela; Chandia, Felipe Vera; Ferre, Felipe; Marin, Gustavo Horacio; Olmos, Ismael; Zimmermann, Ivan R.; Fulone, Izabela; Roldán Saelzer, Juan; Sánchez Salgado, Juan Carlos; Castro Pastrana, Lucila I.; de Souza, Luiz Jupiter Carneiro; Machado Beltrán, Manuel; Tolentino Silva, Marcus; Mena, María Belén; de França Fonteles, Marta Maria; Urtasun, Martín Alejandro
• Año de publicación: 2021
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: CROSS-NATIONAL; DRUG UTILIZATION RESEARCH; LATIN AMERICA; PHARMACOEPIDEMIOLOGY
• Institución: Consejo Nacional de Investigaciones Científicas y Técnicas

Purpose: Drug utilization research (DUR) contributes to inform policymaking and to strengthen health systems. The availability of data sources is the first step for conducting DUR. However, documents that systematize these data sources in Latin American (LatAm) countries are not known. We compiled the potential data sources for DUR in the LatAm region. Methods: A network of DUR experts from nine LatAm countries was assembled and experts conducted: (i) a website search of the government, academic, and private health institutions; (ii) screening of eligible data sources, and (iii) liaising with national experts in pharmacoepidemiology (via an online survey). The data sources were characterized by accessibility, geographic granularity, setting, sector of the data, sources and type of the data. Descriptive analyses were performed. Results: We identified 125 data sources for DUR in nine LatAm countries. Thirty-eight (30%) of them were publicly and conveniently available; 89 (71%) were accessible with limitations, and 18 (14%) were not accessible or lacked clear rules for data access. From the 125 data sources, 76 (61%) were from the public sector only; 46 (37%) were from pharmacy records; 43 (34%) came from ambulatory settings and; 85 (68%) gave access to individual patient-level data. Conclusions: Although multiple sources for DUR are available in LatAm countries, the accessibility is a major challenge. The procedures for accessing DUR data should be transparent, feasible, affordable, and protocol-driven. This inventory could permit a comparison of drug utilization between countries identifying potential medication-related problems that need further exploration.
Fil: Lopes, Luciane C.. University Of Sorocaba; Brasil
Fil: Salas, Daiana Maribel. University of Pennsylvania; Estados Unidos
Fil: Osorio de Castro, Claudia Garcia Serpa. Fundación Oswaldo Cruz; Brasil
Fil: Freitas Leal, Lisiane. McGill University; Canadá
Fil: Doubova, Svetlana V.. Mexican Institute of Social Security; México
Fil: Cañás, Martín. Universidad Nacional Arturo Jauretche; Argentina. Federación Médica de la Provincia de Buenos Aires; Argentina
Fil: Dreser, Anahi. Instituto Nacional de Salud Pública; México
Fil: Acosta, Angela. Universidad ICESI; Colombia
Fil: Oliveira Baldoni, Andre. Federal University of São João Del-Rei; Brasil
Fil: de Cássia Bergamaschi, Cristiane. University of Sorocaba; Brasil
Fil: Marques Mota, Daniel. Brazilian Health Regulatory Agency; Brasil
Fil: Gómez Galicia, Diana L.. Universidad Autónoma del Estado de Morelos; México
Fil: Sepúlveda Viveros, Dino. Universidad de Chile; Chile
Fil: Narvaez Delgado, Edgard. No especifíca;
Fil: da Costa Lima, Elisangela. Universidade Federal do Rio de Janeiro; Brasil
Fil: Chandia, Felipe Vera. Pontificia Universidad Católica de Chile; Chile
Fil: Ferre, Felipe. Universidade Federal de Minas Gerais; Brasil
Fil: Marin, Gustavo Horacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata; Argentina
Fil: Olmos, Ismael. State Health Services Administration; Uruguay
Fil: Zimmermann, Ivan R.. Universidade do Brasília; Brasil
Fil: Fulone, Izabela. University of Sorocaba; Brasil
Fil: Roldán Saelzer, Juan. Instituto de Salud Pública; Chile
Fil: Sánchez Salgado, Juan Carlos. No especifíca;
Fil: Castro Pastrana, Lucila I.. Universidad de Las Américas de Puebla; México
Fil: de Souza, Luiz Jupiter Carneiro. Fundación Oswaldo Cruz; Brasil
Fil: Machado Beltrán, Manuel. Universidad Nacional de Colombia; Colombia
Fil: Tolentino Silva, Marcus. University of Sorocaba; Brasil
Fil: Mena, María Belén. Universidad Central del Ecuador; Ecuador
Fil: de França Fonteles, Marta Maria. Universidade Federal do Ceara; Brasil
Fil: Urtasun, Martín Alejandro. Universidad Nacional Arturo Jauretche; Argentina. Federación Médica de la Provincia de Buenos Aires; Argentina